BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9590564)

  • 41. Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux.
    Wall SC; Gu H; Rudnick G
    Mol Pharmacol; 1995 Mar; 47(3):544-50. PubMed ID: 7700252
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dissection of dopamine and cocaine binding sites on the rat dopamine transporter expressed in COS cells.
    Kitayama S; Morita K; Dohi T; Wang JB; Davis SC; Uhl GR
    Ann N Y Acad Sci; 1996 Oct; 801():388-93. PubMed ID: 8959052
    [No Abstract]   [Full Text] [Related]  

  • 43. Cocaine inhibits the release of MPP+ but not dopamine through the rat dopamine transporter.
    Kitayama S; Morita K; Dohi T
    Eur J Pharmacol; 1996 Aug; 309(1):107-9. PubMed ID: 8864700
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The antidepressant-sensitive dopamine transporter in Drosophila melanogaster: a primordial carrier for catecholamines.
    Pörzgen P; Park SK; Hirsh J; Sonders MS; Amara SG
    Mol Pharmacol; 2001 Jan; 59(1):83-95. PubMed ID: 11125028
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dopamine transporter proline mutations influence dopamine uptake, cocaine analog recognition, and expression.
    Lin Z; Itokawa M; Uhl GR
    FASEB J; 2000 Apr; 14(5):715-28. PubMed ID: 10744628
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Radiation inactivation studies of the dopamine reuptake transporter protein.
    Berger SP; Farrell K; Conant D; Kempner ES; Paul SM
    Mol Pharmacol; 1994 Oct; 46(4):726-31. PubMed ID: 7969052
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reaction of oxidized dopamine with endogenous cysteine residues in the human dopamine transporter.
    Whitehead RE; Ferrer JV; Javitch JA; Justice JB
    J Neurochem; 2001 Feb; 76(4):1242-51. PubMed ID: 11181843
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cationic modulation of human dopamine transporter: dopamine uptake and inhibition of uptake.
    Chen N; Trowbridge CG; Justice JB
    J Pharmacol Exp Ther; 1999 Sep; 290(3):940-9. PubMed ID: 10454463
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dopamine-induced apoptosis in human neuronal cells: inhibition by nucleic acids antisense to the dopamine transporter.
    Simantov R; Blinder E; Ratovitski T; Tauber M; Gabbay M; Porat S
    Neuroscience; 1996 Sep; 74(1):39-50. PubMed ID: 8843076
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular cloning of neurotransmitter transporter genes: beyond coding region of cDNA.
    Vandenbergh DJ
    Methods Enzymol; 1998; 296():498-514. PubMed ID: 9779470
    [No Abstract]   [Full Text] [Related]  

  • 51. Isothiocyanate derivatives of cocaine: irreversible inhibition of ligand binding at the dopamine transporter.
    Boja JW; Rahman MA; Philip A; Lewin AH; Carroll FI; Kuhar MJ
    Mol Pharmacol; 1991 Mar; 39(3):339-45. PubMed ID: 1826041
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis of substituted 3-carbamoylecgonine methyl ester analogues: irreversible and photoaffinity ligands for the cocaine receptor/dopamine transporter.
    Kline RH; Eshleman AJ; Wright J; Eldefrawi ME
    J Med Chem; 1994 Jul; 37(14):2249-52. PubMed ID: 8035432
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of the human gonadotropin-releasing hormone receptor heterologously produced using the baculovirus/insect cell and the Semliki Forest virus systems.
    Marheineke K; Lenhard T; Haase W; Beckers T; Michel H; Reiländer H
    Cell Mol Neurobiol; 1998 Oct; 18(5):509-24. PubMed ID: 9777251
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Resolution of biogenic amine transporter kinetics by rotating disk electrode voltammetry: methodology and mechanistic interpretations.
    Earles C; Wayment H; Green M; Schenk JO
    Methods Enzymol; 1998; 296():660-75. PubMed ID: 9779481
    [No Abstract]   [Full Text] [Related]  

  • 55. Quantitation of rat dopamine transporter mRNA: effects of cocaine treatment and withdrawal.
    Xia Y; Goebel DJ; Kapatos G; Bannon MJ
    J Neurochem; 1992 Sep; 59(3):1179-82. PubMed ID: 1494906
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transporter-mediated actions of R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane.
    Shimazu S; Tsunekawa H; Yoneda F; Katsuki H; Akaike A; Janowsky A
    Eur J Pharmacol; 2003 Dec; 482(1-3):9-16. PubMed ID: 14659999
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of nicotine on dopamine uptake in COS cells possessing the rat dopamine transporter and in PC12 cells.
    Yamashita H; Kitayama S; Zhang YX; Takahashi T; Dohi T; Nakamura S
    Biochem Pharmacol; 1995 Mar; 49(5):742-5. PubMed ID: 7887991
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro and in vivo effects of cocaine and selected local anesthetics on the dopamine transporter.
    Woodward JJ; Compton DM; Balster RL; Martin BR
    Eur J Pharmacol; 1995 Apr; 277(1):7-13. PubMed ID: 7635175
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multisubtrate mechanism for the inward transport of dopamine by the human dopamine transporter expressed in HEK cells and its inhibition by cocaine.
    Earles C; Schenk JO
    Synapse; 1999 Sep; 33(3):230-8. PubMed ID: 10420170
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tolerance in the replacement of the benzhydrylic O atom in 4-[2-(diphenylmethoxy)ethyl]-1-benzylpiperidine derivatives by an N atom: development of new-generation potent and selective N-analogue molecules for the dopamine transporter.
    Dutta AK; Xu C; Reith ME
    J Med Chem; 1998 Aug; 41(17):3293-7. PubMed ID: 9703474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.